Monteleone L, Speciale A, Valenti GE, Traverso N, Ravera S, Garbarino O
After a total of 68 weeks, the semaglutide group experienced an overall average weight reduction of 17.4%
After three to six months, patients should expect to notice benefits
For those seeking an effective, affordable, and well-tolerated option, consider the following differences: Weight Loss Efficacy: Tirzepatide has demonstrated slightly higher average weight loss in clinical trials, sometimes exceeding 15% of body weight
Calorie needs vary depending on: body size activity level muscle mass metabolism weight loss goals While tirzepatide often reduces appetite, eating too little may contribute to: low energy muscle loss weakness slower metabolism poor recovery Many people do better with a moderate calorie deficit instead of severe restriction
Many people find their optimal dose is not the maximum dose